ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716260 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716260; 2) Community: the network communities that were significantly associated with the response to NSC 716260; 3) Molecule: the relationships between components within communities and NSC 716260; 4) MDR: the compounds that were significantly associated with the NSC 716260.

NSC Compound Enrichment Correlation
NSC 704639 Null 3.88440367201721e-005 0.31847353
NSC 705437 Null 3.88440367201721e-005 0.24894292
NSC 654509 Pirarubicin HCl 4.20634348588214e-005 0.26888162
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 4.5458043774469e-005 0.26440698
NSC 674258 Null 4.5458043774469e-005 0.33255522
NSC 132313 Dianhydrogalactitol 5.01016394624202e-007 0.25284208
NSC 101003 Null 5.49145982993963e-005 0.40727254
NSC 337581 ROYLEANONE-7A-FORMYLOXY-6B-HYDROXY-ERU 701 8.79213185492947e-005 0.26497314
NSC 606172 Camptothecin Derivative 8.79213185492947e-005 0.12417392
NSC 618939 Camptothecin Derivative 8.79213185492947e-005 0.20945975
Total:142  Current:141    [First] [Prev] [Next] [Last]